These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 24573216)
21. Medium for toxin production by Clostridium perfringens in continuous culture. Chou G Appl Microbiol; 1971 May; 21(5):794-8. PubMed ID: 4324884 [TBL] [Abstract][Full Text] [Related]
22. Effect of Lactobacillus fermentum on beta2 toxin production by Clostridium perfringens. Allaart JG; van Asten AJ; Vernooij JC; Gröne A Appl Environ Microbiol; 2011 Jul; 77(13):4406-11. PubMed ID: 21602389 [TBL] [Abstract][Full Text] [Related]
23. Development and prevalidation of two different ELISA systems for the potency testing of Clostridium perfringens beta and epsilon-toxoid containing veterinary vaccines. Ebert E; Oppling V; Werner E; Cussler K FEMS Immunol Med Microbiol; 1999 Jul; 24(3):299-311. PubMed ID: 10397315 [TBL] [Abstract][Full Text] [Related]
24. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens. Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605 [TBL] [Abstract][Full Text] [Related]
25. Dynamics of plc gene transcription and alpha-toxin production during growth of Clostridium perfringens strains with contrasting alpha-toxin production. Abildgaard L; Schramm A; Rudi K; Højberg O Vet Microbiol; 2009 Oct; 139(1-2):202-6. PubMed ID: 19559545 [TBL] [Abstract][Full Text] [Related]
30. In vitro inhibition of Clostridium difficile and Clostridium perfringens by commercial probiotic strains. Schoster A; Kokotovic B; Permin A; Pedersen PD; Dal Bello F; Guardabassi L Anaerobe; 2013 Apr; 20():36-41. PubMed ID: 23471038 [TBL] [Abstract][Full Text] [Related]
31. Production and properties of theta-toxin of Clostridium perfringens with special reference to lethal activity. Soda S; Ito A; Yamamoto A Jpn J Med Sci Biol; 1976 Dec; 29(6):335-49. PubMed ID: 192930 [TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers. Saleh N; Fathalla SI; Nabil R; Mosaad AA Anaerobe; 2011 Dec; 17(6):426-30. PubMed ID: 21664285 [TBL] [Abstract][Full Text] [Related]
33. [Production, purification and characterization of some Clostridium perfringens toxins]. Capunzo M; Mariano A; Cavallo R G Batteriol Virol Immunol; 1982; 75(1-6):48-61. PubMed ID: 6315516 [TBL] [Abstract][Full Text] [Related]
34. Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines. Hauer PJ; Clough NE Dev Biol Stand; 1999; 101():85-94. PubMed ID: 10566780 [TBL] [Abstract][Full Text] [Related]
35. The effects of probiotic Bacillus coagulans on the cytotoxicity and expression of alpha toxin gene of Clostridium perfringens type A. Kawarizadeh A; Tabatabaei M; Hosseinzadeh S; Farzaneh M; Pourmontaseri M Anaerobe; 2019 Oct; 59():61-67. PubMed ID: 31125604 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness of Chitosan Nanoparticles in Development of Pentavalent Clostridial Toxoid Vaccine in Terms of Clinical Pathology Elements and Immunological Responses. Fathi Najafi M; Rahman Mashhadi M; Hemmaty M Arch Razi Inst; 2020 Oct; 75(3):385-395. PubMed ID: 33025779 [TBL] [Abstract][Full Text] [Related]
37. [Use of an experimental analytical method for equilibrating nutrient broths for Clostridium perfringens type A growth and toxin formation]. Artemenko VD; Ivanova LG; Nenashev VP; Kuznetsova GI; Ochkina NI Zh Mikrobiol Epidemiol Immunobiol; 1985 Nov; (11):37-41. PubMed ID: 2868592 [TBL] [Abstract][Full Text] [Related]
38. Immunization with recombinant alpha toxin partially protects broiler chicks against experimental challenge with Clostridium perfringens. Cooper KK; Trinh HT; Songer JG Vet Microbiol; 2009 Jan; 133(1-2):92-7. PubMed ID: 18635321 [TBL] [Abstract][Full Text] [Related]
39. [Effect of iron on the growth and toxin formation of Clostridium perfringens type A cultures]. Artemenko VD; Kuznetsova GI; Nenashev VP Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):20-4. PubMed ID: 6098107 [TBL] [Abstract][Full Text] [Related]
40. Production and characterization of Clostridium perfringens recombinant β toxoid. Milach A; de los Santos JR; Turnes CG; Moreira AN; de Assis RA; Salvarani FM; Lobato FC; Conceição FR Anaerobe; 2012 Jun; 18(3):363-5. PubMed ID: 22306065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]